BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15075794)

  • 1. A new polymorphism (Ser362Thr) of the L-myc gene is not associated with lung adenocarcinoma risk and prognosis.
    Spinola M; Conti B; Ravagnani F; Fabbri A; Incarbone M; Cataldo I; Pira E; Pelucchi C; La Vecchia C; Dragani TA
    Eur J Cancer Prev; 2004 Feb; 13(1):87-9. PubMed ID: 15075794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patients.
    Spinola M; Nomoto T; Manenti G; Falvella FS; Brega Massone PP; Conti B; Cataldo I; Valagussa P; Incarbone M; Miyamoto K; Ushijima T; Dragani TA
    Int J Cancer; 2001 Sep; 95(5):329-31. PubMed ID: 11494234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
    Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
    Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
    Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
    Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
    Suzuki H; Yamashiro K
    Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.
    Spinola M; Leoni VP; Galvan A; Korsching E; Conti B; Pastorino U; Ravagnani F; Columbano A; Skaug V; Haugen A; Dragani TA
    Cancer Lett; 2007 Jun; 251(2):311-6. PubMed ID: 17223258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
    Spinola M; Pedotti P; Dragani TA; Taioli E
    Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-myc genotype is associated with different susceptibility to lung cancer in smokers.
    Kumimoto H; Hamajima N; Nishimoto Y; Matsuo K; Shinoda M; Hatooka S; Ishizaki K
    Jpn J Cancer Res; 2002 Jan; 93(1):1-5. PubMed ID: 11802801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
    Iwakawa R; Kohno T; Kato M; Shiraishi K; Tsuta K; Noguchi M; Ogawa S; Yokota J
    Clin Cancer Res; 2011 Mar; 17(6):1481-9. PubMed ID: 21148746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
    Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
    Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
    Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
    Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
    Tefre T; Børresen AL; Aamdal S; Brøgger A
    Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk.
    Falvella FS; Spinola M; Manenti G; Conti B; Pastorino U; Skaug V; Haugen A; Dragani TA
    Lung Cancer; 2007 Apr; 56(1):1-7. PubMed ID: 17194498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
    Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
    Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.
    Spinola M; Falvella FS; Galvan A; Pignatiello C; Leoni VP; Pastorino U; Paroni R; Chen S; Skaug V; Haugen A; Dragani TA
    Lung Cancer; 2007 Mar; 55(3):271-7. PubMed ID: 17145094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.